User menu

Early use of cinacalcet (MIMPARA (R)/SENSIPAR (R)) in dialysis patients enables greatest achievement of NKF-KDOQI (TM) treatment targets for bone metabolism

Bibliographic reference Frazao, J. M. ; Messa, P. ; Cunningham, J. ; Evenepoel, P. ; Shahapuni, I. ; et. al. Early use of cinacalcet (MIMPARA (R)/SENSIPAR (R)) in dialysis patients enables greatest achievement of NKF-KDOQI (TM) treatment targets for bone metabolism.43rd Annual Congress of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA) (Glasgow(Scotland), Jul 15-18, 2006). In: Nephrology, Dialysis, Transplantation, Vol. 21, p. 8-9 (2006)
Permanent URL http://hdl.handle.net/2078.1/59922